merck verona pharma - Search News

News

Merck eyes $10B buyout of Verona Pharma

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

· 3d · on MSN

Merck to Buy Verona Pharma in $10 Billion Deal

NJBIZ · 4d

Merck to acquire Verona Pharma in $10B COPD drug deal

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...

4don MSN

Merck buys Raleigh drugmaker for $10 billion, drawn by new COPD treatment

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

4don MSN

Merck shells out $10 billion for London-based lung therapy firm Verona

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

Verona Pharma Shares Pop Premarket on Report of Merck Takeover

Verona Pharma shares jumped in premarket trading Wednesday after the Financial Times reported that Merck & Co. is nearing a $10 billion deal to buy the U.K. drugmaker.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results